Diagnosis, staging, and evaluation of treatment response in patients with amyloidosis using amyloid PET imaging

Diagnosis, staging, and evaluation of treatment response in patients with amyloidosis using amyloid PET imaging - Amyloid deposits detection using amyloid PET

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019734

Enrollment

Registered

2015-11-10

Start date

2015-11-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amyloidosis

Interventions

At the time of diagnosis of amyloidosis, amyloid PET scan is performed. In the case whose amyloidosis is treatable situation, amyloid PET scan will be performed again after initiating or completing th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adult patients who are diagnosed as any type of amyloidosis 2. Patients who can provide written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients who cannot provide consent 2. Any patients who are considered ineligible by study manager

Design outcomes

Primary

Measure	Time frame
Degree of PET tracer uptake in each organ	—

Countries

Japan

Contacts

Public ContactNagaaki Katoh

Shinshu University Department of Medicine (Neurology and Rheumatology)

nagaaki@shinshu-u.ac.jp+81-263-37-2673

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026